key: cord-0794548-8dqtd6kb
authors: Urbina, Jesica; Monks, Stormy M; Ochoa, Luis; Stump, Robert F; Wicker, Ryan B; Danek, Chris; Torres, Victor I; Crawford, Scott B
title: Development and Evaluation of an Automated Manual Resuscitator-Based Emergency Ventilator-Alternative
date: 2021-03-01
journal: Cureus
DOI: 10.7759/cureus.13642
sha: 42f7f4e7f6dfb835db100dda9c2e4f186d454a63
doc_id: 794548
cord_uid: 8dqtd6kb

Mass casualty incidents such as those that are being experienced during the novel coronavirus disease (COVID-19) pandemic can overwhelm local healthcare systems, where the number of casualties exceeds local resources and capabilities in a short period of time. The influx of patients with lung function deterioration as a result of COVID-19 has strained traditional ventilator supplies. To bridge the gap during ventilator shortages and to help clinicians triage patients, manual resuscitator devices can be used to deliver respirations to a patient requiring breathing support. Bag-valve mask (BVM) devices are ubiquitous in ambulances and healthcare environments, however require a medical professional to be present and constantly applying compression to provide the patient with respirations. We developed an automated manual resuscitator-based emergency ventilator-alternative (AMREV) that provides automated compressions of a BVM in a repetitive manner and is broadly compatible with commercially-available BVM devices approximately 5 inches (128 mm) in diameter. The AMREV device relieves the medical professional from providing manual breathing support and allows for hands-free operation of the BVM. The AMREV supports the following treatment parameters: 1) adjustable tidal volume (V(T)), 2) positive end-expiratory pressure (PEEP) (intrinsic and/or external), 3) 1:1 inspiratory: expiratory ratio, and 4) a controllable respiratory rate between 10-30 breaths per minute. The relationship between the inherent resistance and compliance of the lung and the delivered breaths was assessed for the AMREV device. Adjustable V(T) of 110-700 ml was achieved within the range of simulated lung states. A linear increase in mean airway pressure (P(aw)), from 10-40 cmH(2)O was observed, as the resistance and compliance on the lung model moved from normal to severe simulated disease states. The AMREV functioned continuously for seven days with less than 3.2% variation in delivered V(T) and P(aw). Additionally, the AMREV device was compatible with seven commercially-available BVM setups and delivered consistent V(T) and P(aw) within 10% between models. This automated BVM-based emergency-use resuscitator can provide consistent positive pressure, volume-controlled ventilation over an extended duration when a traditional ventilator is not available. True ventilator shortages may lead to manual resuscitators devices such as the AMREV being the only option for some healthcare systems during the COVID-19 pandemic.

In late December 2019, an outbreak of a novel coronavirus disease was reported in Wuhan, China, and was subsequently identified as a pandemic [1] . Severe COVID-19 disease can result in death due to the development of an acute respiratory distress syndrome (ARDS)-like illness [2] . Invasive ventilation is indicated for adult patients with ARDS-associated respiratory difficulty [3, 4] ; however, the influx of patients with lung function deterioration as a result of COVID-19 has strained traditional ventilator supplies [1, [5] [6] [7] . To bridge the gap during ventilator shortages, automated manual resuscitator devices can be used to deliver respirations to a patient requiring breathing support [8] .

There are currently many open-source solutions that seek to disseminate manual resuscitator (bag-valve mask; BVM) ventilator designs with the hope of bridging the gap during the COVID-19 pandemic [9] [10] [11] .

However, there are important design considerations when using BVM devices for this type of off-label use to prevent further lung injury from barotrauma [12] . First, the design should ensure that the device does not degrade the BVM performance with regard to pressure, V T, and flow waveforms from repetitive device motion. Durability testing has to be performed not only on the mechanical system but also on the BVM device. Secondly, even with a fixed BVM compression setting, the V T delivered is dependent on the resistance of the airway and the compliance of the lungs [13] . The only respiratory parameter that can be controlled by most devices is the respiratory rate, and while the United States (U.S.) Food and Drug Administration (FDA) has issued emergency use authorizations for devices in which V T can be selected [14] , designs with a fixed stroke length (compression setting) lead to inconsistent V T delivered as pulmonary parameters change. Ventilator designs should measure expired volumes or predict V T across ventilator settings for specific pulmonary resistance and compliance parameters.

For this work, it was hypothesized that a low-cost, emergency-use automated BVM-based device could consistently deliver mechanical respirations with a variety of widely commercially-available BVMs. The specific aims were to 1) rapidly design and develop a volume-controlled automated manual resuscitatorbased emergency ventilator-alternative with user-adjustable volume and respiratory rate, 2) evaluate the parameters of V T , rate, and mean airway pressure over different resistance and compliance settings that would be representative of patients with varying lungs states, and 3) establish longevity and implementation of the device across multiple BVM models.

The designed device is a low-cost emergency ventilator-alternative with adjustable stroke length and a housing enclosure that was developed to constrain BVM deformation in a reliable manner to ensure consistent V T is delivered for each pulmonary parameter. The device, an automated manual resuscitatorbased emergency ventilator-alternative (AMREV), was assessed for V T delivered, mean airway pressure (P aw ), and respiratory rate for different simulated models of lung disease. To ensure that variation among commercially-available BVMs did not create the risk of going over threshold V T or P aw , design considerations were made to ensure that the ventilator device would be widely compatible with BVM models measuring up to approximately 128 mm (5 inches) in diameter, with a 1.5 L air reservoir.

The AMREV was created using additive manufacturing (hereafter referred to as 3D-printing) technology combined with traditional build techniques that allowed for rapid design iterations and assessments. The design uses an eccentric attachment of a rod and piston assembly to a cam plate driven by a simple lowvoltage geared motor to compress the BVM ( Figure. 1) . The rod attachment point on the cam controls the amount of compression of the manual resuscitator bag and therefore V T . Respiratory rate of the 30 rpm (without a load) geared motor is controlled by a hardware-based pulse-width modulation (PWM) controller. Full user assembly and operation instructions are included in the supplemental materials Appendix A 'Instructions for Use'. The 3D-printed components of the device were made of polycarbonate material fabricated on Stratasys 400 mc, 450 mc, and 900 mc Fortus series printers (Rehovot, Israel). Polycarbonate was selected due to its strength, availability, durability, and acceptability in medical applications. Electrical power to the AMREV unit was provided by a commercially-available low-voltage 12V 2A DC power supply. Electrical connections were made within the enclosed 3D printed motor mount, and secured using screw terminals, solder, and commercial spade clips. Hitch pin clips were used to secure the clevis pins of the mechanical piston rod, a set screw is used to attach the adjustable-length cam to the motor shaft, and screws hold the electronics cover to the motor mount.

A rapid, iterative design/simulate, build, and test approach was used to converge on the final design. The main design considerations included 1) compatibility with commercial BVMs, 2) a piston-cylinder and sliding mechanism approach for bag compression, 3) device conforming to BVM shape to reduce stress, 4) minimizing weight, 5) minimizing ventilation dead space volume by allowing mounting near the patient's mouth using a bedside IV pole, 6) an electric motor needed to drive the mechanism, and 7) compatibility with additive manufacturing (AM); specifically, fused deposition modeling (FDM) with polycarbonate material. Dimensions were selected during the design phase to ensure ease of assembly, operation on a sliding contact mechanism, and the specified range of piston travel. All were achieved by accounting for tolerances of the FDM process. To reduce variability in the manufacturing process and in device performance, the design excluded the use of support structures on the critical piston linear slide or BVM contact surfaces. Solid modeling was performed in Solidworks (Version 2019-20). Prototyping by 3D printing allowed rapid production and advancement through six major design iterations. A future publication will discuss the use of simulation by finite element analysis (FEA) in parallel with the AMREV design iterations as a precursor to device-life testing.

Prototypes were assessed for general function, piston movement, and length of piston travel needed to compress the manual resuscitator to deliver an approximate tidal volume between 200-700 ml in a patient with normal lung function with resistance 5 cmH 2 O.L -1 .s -1 and compliance 50 ml.cmH 2 O -1 . Device assessments were performed with a RespiTrainer Advance™ and QuickLung® (IngMar Medical Ltd., Pittsburg, PA, USA). After functional confirmation, specific parameter testing and device calibration was performed using an ASL 5000™ Breathing Simulator. (IngMar Medical Ltd., Pittsburg, PA, USA). The same IngMar® ASL 5000 was used for all testing parameters. Following data collection, the ASL 5000 was connected to a hospital-certified ventilator to compare calibration of V T and pressures. The device was found to correlate within 5% across assessed parameters.

To measure the effect of patient lung resistance and compliance on V T delivered, variation was assessed across different pulmonary parameter models. The initial disease states for testing were chosen based on discussions with a pulmonologist

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Ventilator management strategies for adults with acute respiratory distress syndrome

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome

The toughest triage-allocating ventilators in a pandemic

Critical supply shortages-the need for ventilators and personal protective equipment during the Covid-19 pandemic

Assessing the capacity of the US health care system to use additional mechanical ventilators during a large-scale public health emergency

Evaluation of bag-valve-mask ventilation in manikin studies: what are the current limitations?

Openlung emergency medical ventilator

MPS open-source ventilator

MIT emergency ventilator

The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia

Respiratory mechanics in mechanically ventilated patients

FDA combating covid-19 with medical devices

in medical electrical equipment -part 2-80: particular requirements for basic safety and essential performance of ventilatory support equipment for ventilatory insufficiency

Association for the advancement of medical instrumentaiton (AAMI), emergency use resuscitator system (EURS) design guidance

Accessed

CareFusion AirLife® manual self-inflating resuscitation devices

Rusch manual resuscitator bag

Accessed

Ferno single patient use bvm with medication and monitoring port

Laerdal silicone resuscitators

Food and drug administration emergency use authorization for ventilators during covid-19 pandemic

The authors would like to thank the Training and Educational Center for Healthcare Simulation (TECHS) at Texas Tech University Health Sciences Center (TTUHSC) El Paso for providing testing equipment. Additional design and manufacturing support was provided by the UTEP W.M. Keck Center for 3D Innovation. A specific acknowledgement to each of the staff for their contributions including Mireya Flores, Frank Medina, David Espalin, Nikki Martinez, Jose Coronel, Angel Vega, Leonardo Gutierrez, and Mahesh Tonde. Material donation and additional manufacturing assistance was also supported through the generous contribution of Stratasys Co. Ansys Inc. supported simulation modeling. The authors would also like to acknowledge the support and insight from Joel Libove (Furaxa) on the electrical design of the device; and Cindy Domecus for guidance in the U.S. FDA submission and review process.

Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Chris Danek declare(s) Licensing agreement from Bessel LLC. We declare that one author, Chris Danek, director of Bessel LLC, has licensed the rights from Texas Tech University Health Sciences Center El Paso to distribute the innovation. The other authors declare that there are no conflicts of interest. No additional funding was provided for this project. . Intellectual property info: The members of the Texas Tech Office of Research Commercialization (Cameron Smith, Hutton Jones) are working directly with the Office of Technology Commercialization (Chao Zhang) and the Assistant Vice President (Ivette Savina) at UTEP. Both entities are supportive of our efforts, and are committed to avoiding any intellectual property impediments. Both TTU and UTEP are aware of the urgency of this project, and there is tentative agreement that the device will be offered with a 1 year low cost option, and thereafter a royalty agreement will be established. There also is agreement that the Universities will file patents and other intellectual property protections jointly. We are aware of a utility patent (US 6155257) on a similar concept. This patent expired on 10/7/2018. Our preliminary patent search has not revealed any other conflicting prior art. . Other relationships: All authors have declared that there are no